Tuesday, May 24, 2016 11:21:51 AM
The FDA has set a user fee goal date under the Prescription Drug User Fee Act of May 27, 2016, which is the target date for the FDA to complete its review of the sNDA.
Recent VNDA News
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/09/2024 09:15:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 11:07:02 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 08:06:04 PM
- Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results • PR Newswire (US) • 05/08/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:51:10 PM
- Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak • PR Newswire (US) • 05/07/2024 03:16:00 PM
- Vanda Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 8, 2024 • PR Newswire (US) • 04/30/2024 08:30:00 PM
- Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals • GlobeNewswire Inc. • 04/25/2024 12:05:51 PM
- Vanda Pharmaceuticals Reacts to U.S. Supreme Court's Denial of its Petition in HETLIOZ® ANDA Litigation • PR Newswire (US) • 04/22/2024 11:13:00 PM
- Vanda Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan • PR Newswire (US) • 04/17/2024 02:21:00 PM
- Vanda Pharmaceuticals Confirms Rejection of Unsolicited Takeover Proposals from Future Pak • PR Newswire (US) • 04/17/2024 01:02:00 PM
- Biotech Catches Major Premarket Bid Following FDA Approval • AllPennyStocks.com • 04/03/2024 02:25:00 PM
- Vanda Pharmaceuticals' Fanapt® (iloperidone) Receives U.S. FDA Approval for the Acute Treatment of Bipolar I Disorder • PR Newswire (US) • 04/02/2024 10:10:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 09:31:09 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:50:29 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:48:50 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:47:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/06/2024 09:46:00 PM
- Vanda Pharmaceuticals Announces FDA Update for supplemental NDA for HETLIOZ® in the Treatment of Insomnia • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:14:13 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:12:36 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:10:28 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:08:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/05/2024 02:06:48 AM
Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM